help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-2090
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/5/1693    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mishra, S. K.
Right arrow Articles by Goswami, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mishra, S. K.
Right arrow Articles by Goswami, R.
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Thyroid
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 5 1693-1696
Copyright © 2007 by The Endocrine Society

Plasma Adrenocorticotropin (ACTH) Values and Cortisol Response to 250 and 1 µg ACTH Stimulation in Patients with Hyperthyroidism before and after Carbimazole Therapy: Case-Control Comparative Study

Sunil Kumar Mishra, Nandita Gupta and Ravinder Goswami

Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi 110029, India

Address all correspondence and requests for reprints to: Ravinder Goswami, M.D., D.M., Associate Professor, Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India 110029. E-mail: gosravinder{at}hotmail.com.

Context: Although the production and metabolic clearance rate of cortisol is increased during thyrotoxic state, the net effect on adrenocortical reserves is not clear.

Objective: We assessed circulating ACTH levels, cortisol binding globulin (CBG), and adrenocortical reserves in hyperthyroid patients (before and after carbimazole therapy) and healthy controls.

Design and Setting: This was a case-control investigative study in a tertiary care setting.

Patients and Methods: Plasma ACTH and free cortisol index (FCI; serum cortisol/CBG) were measured in 49 consecutive patients with hyperthyroidism and 50 controls. ACTH1–24 stimulation tests (250 and 1 µg) were carried out in the first 29 patients and 15 controls. Peak FCI less than the mean –3 SD of healthy controls was considered subnormal. ACTH1–24 stimulation tests were repeated in 24 patients in the euthyroid state.

Results: The mean basal plasma ACTH and FCI were higher and CBG was lower in thyrotoxic patients in comparison with controls. The peak cortisol was less than 18 µg/dl in 10 of 29 and 14 of 29 on 250 and 1 µg ACTH1–24 stimulation. Peak FCI was subnormal only in three of 27 (11.1%) and two of 21 (7.4%) on 250 and 1 µg ACTH1–24 stimulation, respectively. The mean plasma ACTH, basal FCI, and subnormal peak FCI (two of the three) normalized after euthyroidism. Plasma ACTH and FCI did not correlate with severity of thyrotoxicosis.

Conclusions: Up to 11% of thyrotoxics have subnormal peak FCI on ACTH1–24 stimulation. Such changes occur despite high basal plasma ACTH and FCI. Use of FCI, rather than total cortisol, is required for the interpretation of cortisol values in thyrotoxicosis due to the variation in CBG.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society